The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Cantargia AB ( ($SE:CANTA) ) has shared an update. Cantargia AB has published preclinical data in Cancer Discovery, highlighting the potential of ...